These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 34324256)

  • 21. Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
    Karaba AH; Zhou W; Li S; Aytenfisu TY; Johnston TS; Akinde O; Eby Y; Abedon AT; Alejo JL; Qin CX; Thompson EA; Garonzik-Wang JM; Blankson JN; Cox AL; Bailey JR; Klein SL; Pekosz A; Segev DL; Tobian AAR; Werbel WA
    Clin Infect Dis; 2023 Feb; 76(3):e495-e498. PubMed ID: 35959783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
    PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
    Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
    JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study.
    Trapani S; Masiero L; Puoti F; Rota MC; Del Manso M; Lombardini L; Riccardo F; Amoroso A; Pezzotti P; Grossi PA; Brusaferro S; Cardillo M; ;
    Am J Transplant; 2021 Jul; 21(7):2509-2521. PubMed ID: 33278850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients.
    Peters LL; Raymer DS; Pal JD; Ambardekar AV
    JAMA Cardiol; 2022 Jun; 7(6):651-654. PubMed ID: 35475896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients.
    Karaba AH; Zhu X; Benner SE; Akinde O; Eby Y; Wang KH; Saraf S; Garonzik-Wang JM; Klein SL; Bailey JR; Cox AL; Blankson JN; Durand CM; Segev DL; Werbel WA; Tobian AAR
    Transplantation; 2022 Apr; 106(4):835-841. PubMed ID: 35085183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world Evidence of COVID-19 Vaccines Effectiveness in Solid-organ Transplant Recipient Population in Colombia: A Study Nested in the Esperanza Cohort.
    Pinto-Álvarez M; Fernández-Niño JA; Arregocés-Castillo L; Rojas-Botero ML; Palacios AF; Galvis-Pedraza M; Ruiz-Gomez F
    Transplantation; 2023 Jan; 107(1):216-224. PubMed ID: 36228269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of COVID 19 vaccination on kidney recipients.
    Marzieh L; Elahe P; Habib R; Maryam P; Arefeh J; Elnaz E; Sanaz D
    Transpl Immunol; 2022 Oct; 74():101658. PubMed ID: 35777613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada.
    Naylor KL; Kim SJ; Smith G; McArthur E; Kwong JC; Dixon SN; Treleaven D; Knoll GA
    Am J Transplant; 2022 Sep; 22(9):2228-2236. PubMed ID: 35578576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.
    Malhotra S; Mani K; Lodha R; Bakhshi S; Mathur VP; Gupta P; Kedia S; Sankar J; Kumar P; Kumar A; Ahuja V; Sinha S; Guleria R; ; Dua A; Ahmad S; Sathiyamoorthy R; Sharma A; Sakya T; Gaur V; Chaudhary S; Sharma S; Madan D; Gupta A; Virmani S; Gupta A; Yadav N; Sachdeva S; Sharma S; Singh S; Pandey A; Singh M; Jhurani D; Sarkar S; Lokade AK; Mohammad A; Pandit S; Dubey R; Singh AK; Gohar N; Soni D; Bhattacharyya A; Rai S; Tummala S; Gupta I; Shukla S
    JAMA Netw Open; 2022 Jan; 5(1):e2142210. PubMed ID: 34994793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high-risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves.
    Zeitler K; Piccicacco N; O'Neal M; Montero J; Myers A; Strebig D; Nestler S; Anger LB; Kim K
    Transpl Infect Dis; 2023 Aug; 25(4):e14095. PubMed ID: 37378536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.
    Malinis M; Cohen E; Azar MM
    Am J Transplant; 2021 Aug; 21(8):2916-2918. PubMed ID: 34101990
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 Vaccination in Solid-Organ Transplant: A Real-World Multicenter Experience.
    Khomane P; Meshram HS; Banerjee S; Tambi P; Patel H; Patel A; Makwana MJ; Sharma S; Mishra V; Kute VB
    Exp Clin Transplant; 2022 Sep; 20(9):805-810. PubMed ID: 36169102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives on COVID-19 vaccination among kidney and pancreas transplant recipients living in New York City.
    Tsapepas D; Husain SA; King KL; Burgos Y; Cohen DJ; Mohan S
    Am J Health Syst Pharm; 2021 Nov; 78(22):2040-2045. PubMed ID: 34185824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying excess deaths among solid organ transplant recipients in the COVID-19 era.
    Massie AB; Werbel WA; Avery RK; Po-Yu Chiang T; Snyder JJ; Segev DL
    Am J Transplant; 2022 Aug; 22(8):2077-2082. PubMed ID: 35294799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients.
    Demir E; Dheir H; Safak S; Serra Artan A; Sipahi S; Turkmen A
    Vaccine; 2022 May; 40(24):3313-3319. PubMed ID: 35504784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls.
    Vinson AJ; Anzalone AJ; Sun J; Dai R; Agarwal G; Lee SB; French E; Olex A; Ison MG; Mannon RB;
    Am J Transplant; 2022 Oct; 22(10):2418-2432. PubMed ID: 35674237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees.
    Kojima N; Roshani A; Brobeck M; Baca A; Klausner JD
    Int J Infect Dis; 2022 May; 118():21-23. PubMed ID: 35151852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of Severe SARS-CoV-2 Infection in Fully Vaccinated Solid Organ Transplant Recipients.
    Marinaki S; Xagas E; Tsoutsoura P; Katsaros D; Korogiannou M; Boletis IN
    Transplant Proc; 2022; 54(6):1405-1408. PubMed ID: 35074163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
    Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
    Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.